(Q42510518)

English

Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alterations in cerebrospinal fluid chemokines are associated with maraviroc exposure and in vivo metabolites measurable by magnetic resonance spectroscopy (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

cerebrospinal fluid

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

object named as

Myra O McClure

5

0 references

Simon D Taylor-Robinson

7

object named as

Simon D Taylor-Robinson

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Lucy J Garvey

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Joanna M Allsop

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Steve Kaye

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

David Back

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Alan Winston

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

222-227

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

describes a project that uses

NMR spectroscopy

1 reference

based on heuristic

inferred from title

The neuropathogenesis of AIDS

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

HIV-1 infection and AIDS: consequences for the central nervous system

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Macrophage inflammatory protein-1

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

The C-X-C chemokine IP-10 stimulates HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Quantitation of simulated short echo time 1H human brain spectra by LCModel and AMARES.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Probabilistic anatomic mapping of cerebral blood flow distribution of the middle cerebral artery

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity.

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility

1 reference

https://api.crossref.org/works/10.1310%2FHCT1304-222

21 January 2018

Identifiers

10.1310/HCT1304-222

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42510518&oldid=2103318787"